ABVC BioPharma Inc - Real-time stock metrics, market data, and comprehensive analysis
Fetching stock data...
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions (such as Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center) and then out-licensing the products to international pharmaceutical companies for pivotal Phase III studies and, eventually, generating global sales. The Company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus ® ) under development.
No news available
Limited Time
Get premium stock ratings, research, analyst insights, and portfolio tools with a limited-time discount.
25% off Seeking Alpha Premium through July 7.
Claim 25% discountSponsored partner offer: The 25% Seeking Alpha Premium discount is available for a limited time. Terms apply.